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Abstract  
Parkinson’s disease is a neurodegenerative disorder caused by loss of dopamine neurons in the substantia 
nigra pars compacta. Tremor, rigidity, and bradykinesia are the major symptoms of the disease. These 
motor impairments are often accompanied by affective and emotional dysfunctions which have been large-
ly studied over the last decade. The aim of this study was to investigate emotional processing organization 
in the brain of patients with Parkinson’s disease and to explore whether there are differences between rec-
ognition of different types of emotions in Parkinson’s disease. We examined 18 patients with Parkinson’s 
disease (8 men, 10 women) with no history of neurological or psychiatric comorbidities. All these patients 
underwent identical brain blood oxygenation level-dependent functional magnetic resonance imaging for 
emotion evaluation. Blood oxygenation level-dependent functional magnetic resonance imaging results 
revealed that the occipito-temporal cortices, insula, orbitofrontal cortex, basal ganglia, and parietal cortex 
which are involved in emotion processing, were activated during the functional control. Additionally, 
positive emotions activate larger volumes of the same anatomical entities than neutral and negative emo-
tions. Results also revealed that Parkinson’s disease associated with emotional disorders are increasingly 
recognized as disabling as classic motor symptoms. These findings help clinical physicians to recognize the 
emotional dysfunction of patients with Parkinson’s disease. 
Key Words: Parkinson’s disease; emotion; processing; Blood oxygenation level-dependent functional magnetic 
resonance imaging; brain; activation; dopamine; neural regeneration 
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Introduction
Parkinson’s disease (PD) is a neurodegenerative disease 
caused by progressive degeneration of nigrostriatal dopa-
minergic pathways. The major symptoms consist of motor 
problems including tremor, rigidity, and bradykinesia. 
However, affective and emotional impairments have been 
also reported (Peron et al., 2012). Thus, numerous studies 
have been conducted to elucidate PD-related impairment in 
affective processing (Gray and Tickle-Degnen, 2010). Sur-
prisingly, these studies produced very different results (Gray 
and Tickle-Degnen, 2010). Some research groups described 
global emotion impairment while others reported problems 
in specific emotion processing. In contrast, some authors 
did not report any deficit (Ricciardi et al., 2017). The differ-
ences may result from confounding factors, including the 
stage of the disease, medication status, and comorbidities. 
However, it is well known that patients with PD suffer from 
reduced facial expressivity (hypomimia) and have difficulties 
in interpreting the emotional facial expressions of others, 
especially for non-positive emotions (Arriatti et al., 2008). 
Most studies regarding emotion in PD were based on 
behavioral, cognitive and physiological measurements of 
emotion recognition (Adolphs et al., 1998; Pell and Leonard, 
2005; Bowers et al., 2006; Suzuki et al., 2006; Wieser et al., 
2006; Laweence et al., 2007; Clark et al., 2008; Dara et al., 
2008; Lotze et al., 2009; Miller et al., 2009; Schienle et al., 
2015). However, all of these studies have addressed only one 
aspect of emotions (Schuenle et al., 2015; Ricciardi et al., 
2017). To date, few studies have investigated emotional is-
sues in PD using fMRI (Lotze et al., 2009). To the best of our 
knowledge, this is the first fMRI study exploring all aspects 
of emotions (positive, negative, and neutral) in a homoge-
neous population of patients with PD. The goal of this study 
was to investigate emotion organization in the brain of pa-
tients with PD and to explore whether there are differences 
between recognition of different types of emotions.
  
Subjects and Methods   
Patient selection
This study was conducted according to the national ethical 
guidelines and regulations, which are mostly compliant with 
the National Institute of Health standards. The approval of 
the local ethical committee ‘Comité d’Etique Hospitalo-uni-
versitaire de Fez, Fez; Morocco’ was obtained (Reference: 
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ECR 09/2018). 
Eighteen patients with idiopathic PD including 16 patients 
having bilateral lesions and two patients having right-sided 
lesions were recruited for the study. The studied patients 
had no neurological or psychiatric comorbidities. The diag-
nosis of PD was established by a certified neurologist with 
advanced training in movement disorders. The diagnostic 
criteria were based on clinical symptoms including bradyki-
nesia/hypokinesia and atypical movement disorders such as 
mix, myoclonic, task dependant, postural inaugural tremor, 
dopamine resistant tremor, isolated tremor at rest. Non mo-
tor symptoms are also considered. None of the patients had 
received deep brain stimulation before. 
All patients underwent clinical assessment of motor dis-
orders using the Unified Parkinson’s Disease Rating Scale 
(UPDRS) section V (Goetz et al., 2010). Neurological exam-
ination was performed the day before scanning. All patients 
were also assessed by a psychiatrist using the Beck Depres-
sion Inventory-II (BDI-II) (scale) (Beck et al., 1996) to rule 
out a depressive propensity which might interfere wih affec-
tive processing. All participants had normal vision.
All included patients were under L-dopa treatment. In 
addition, some of them simultaneously received other par-
kinsonian drugs trihexyphenidyl hydrochloride (n = 4), 
piribedil (n  = 3), or a mixture of these drugs (n  = 2). Med-
ication was not discontinued prior to the fMRI session and 
all patients were investigated on the ON state of their dopa-
minergic medication cycle. 
Both written and verbal informed consents were obtained 
from each patient. The demographic and clinical parameters 
of included patients are summarized in Table 1.
Emotion paradigm design
Emotion stimuli were based on the international affective 
picture system that was developed by the Center for the 
Study of Emotion and Attention, University of Florida, 
Gainesville, FL, USA (https://csea.phhp.ufl.edu/media/
requestform.html). In addition, the used pictures consisted 
of cultural experience adapted and validated pictures in the 
Moroccan context. 
Twenty-seven pictures were used in our experiment. The 
images were presented to the participants with formal in-
struction to simply experience the presented emotion. 
We used a block design, each block comprising three 
different types of pictures, positive (e.g., joyful baby, hap-
py family), negative (e.g., attacks by animals, craniofacial 
trauma) or neutral emotions (e.g., nature scenes) (Figure 
1). Each picture was displayed for 6 seconds followed by the 
second and third pictures for the same duration and emo-
tion. The single display of picture for 6 seconds was justified 
by avoiding habituation that starts at the ninth second of 
display. Thus each emotion stimulus lasted for 18 seconds 
(ON condition). Then rest phase (OFF condition) started 
when pictures vanished and lasted 18 seconds (Figure 2). 
Each block of stimulus was displayed in a pseudo-random-
ized order for all the included patients with PD.
The experiment was designed to last the shortest time pos-
sible to avoid potential motion artifacts during fMRI scanning 
sessions. In this study, the whole experiment lasted 342 seconds.
Blood oxygenation level-dependent functional magnetic 
resonance imaging (BOLD-fMRI) acquisition protocol
The BOLD-fMRI protocol used was identical for all patients. 
All image data acquisitions were achieved in MRI Unit, Ra-
diology and Clinical Imaging Department of the University 
Hospital of Fez, Morocco.
A 1.5-Tesla MRI system (Sigma, General Electric; Milwau-
kee, WI, USA) was used to acquire all brain BOLD-fMRI 
and also anatomical MRI data series.
Image acquisition was achieved using single-shot gradi-
ent-echo echo-planar imaging sequence. This MRI approach 
was shown to be very sensitive to T2* effect originated by 
increased BOLD phenomena. This reflects the level of func-
tional activity within the cortical brain tissue (Boujraf et al., 
2006, 2009, 2017; Bucher et al., 2006; Halder et al., 2007; Be-
laïch et al., 2015, 2016, 2017).
BOLD-fMRI acquisition parameters were set according 
to the following configurations: repetition time = 3000 ms, 
echo time = 55 ms, slice thickness = 5 mm, field of view = 
240 mm. All acquired slices were set in the axial orientation. 
The acquisition of a single volume of brain was achieved 
within 3 seconds. The full BOLD-fMRI acquisition protocol 
allows acquiring 114 brain volumes within 342 seconds. The 
anatomical MRI data were also acquired. 
Data post-processing and image generation 
The BOLD-fMRI image data were processed using the Sta-
tistical Parametric Mapping package version 12 (SPM12, 
2012; http://www.fil.ion.ucl.ac.uk/spm; Wellcome Depart-
Table 1 Demographic and clinical characteristics of our PD patients
Case
Age 
(year) Sex 
Family 
history 
of PD
Symptom 
duration 
(year)
Hoehn 
and Yahr 
stage Treatment
1 65 M Yes 11 III L-dopa + THC
2 63 F No 2 II L-dopa
3 60 F Yes 6 III L-dopa + THC
4 60 F No 7 III L-dopa + THC + 
Piribedil
5 54 F No 1 I L-dopa
6 83 M No 4 II L-dopa + THC
7 49 M No 2 II L-dopa + THC
8 69 F No 1 II L-dopa
9 56 M No 12 III L-dopa + Piribedil
10 65 M No 3 II L-dopa
11 79 F No 3 III L-dopa
12 63 M Yes 4 III L-dopa
13 62 F No 6 III L-dopa + Piribedil
14 50 M No 8 III L-dopa+ Piribedil
15 45 M Yes 4 I L-dopa
16 66 F No 10 III L-dopa + THC + 
Piribedil
17 56 F No 2 II L-dopa
18 57 F No 8 III L-dopa 
PD: Parkinson’s disease: F: female; M: male; L-dopa: levodopa; THC: 
trihexyphenidyle chlorhydrate. 
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Figure 1 Blood oxygenation level-dependent functional magnetic resonance imaging paradigm components showing the main emotional 
tasks (positive, negative, and neutral). 
Each emotional task was repeated three times with unique images, e.g. each picture was displayed once. 
ment of Cognitive Neurology, London, UK). The statistical 
model used by SPM12 was general linear model approach. 
All brain MRI image volumes acquired were used in the 
post-processing steps.
The post-processing steps with SPM12 included realign-
ment, co-registration, and spatial normalization in the Mon-
treal Neurological Institute template (Boujraf et al., 2006, 
2009, 2017; Bucher et al., 2006; Halder et al., 2007; Belaïch et 
al., 2015, 2016, 2017).
Indeed, the gradient-echo EPI image data underwent 
realignment using a rigid-body transformation to the first 
volume of the time series for each patient. Subsequently, the 
image data were spatially smoothed using a Gaussian filter 
Full width at half maximum (FWHM 8 × 8 × 8 mm) and 
then spatially normalized (Boujraf et al., 2006, 2009, 2017; 
Bucher et al., 2006; Halder et al., 2007; Belaïch et al., 2015, 
2016, 2017). 
All cerebral activations were rendered onto brain slices of 
T1-weighted MRI image or on the surface of the standard 
brain of Montreal Neurological Institute, Montreal, Que-
bec, Canada. The task was designed according to the box-
car pattern and convolved with the functional hemodynamic 
response recorded in the brain. The brain areas that were sig-
nificantly activated were decided. Each voxel element was sta-
tistically processed using SPM12 (Boujraf et al., 2006, 2009, 
2017; Bucher et al., 2006; Halder et al., 2007; Belaïch et al., 
2015, 2016, 2017). A P-value less than 0.01 was considered 
statistically significant. The calculated BOLD activation maps 
were overlaid on anatomical images.
Quantitative evaluation of individual activation maps 
Each calculated activation map of individual patients was 
evaluated and scored to reflect the activation level originated 
by each emotion (namely positive, negative, and neutral).
Statistical analysis
One-way analysis of variance was used for comparison of 
quantitative data between paired emotion categories (namely 
positive versus negative, positive versus neutral, and nega-
tive versus neutral). A value of P < 0.05 was considered to be 
statistically significant. 
Results
Clinical assessment results
This study included 18 patients, consisting of 10 women 
and 8 men, with a mean age of 61 (45–86) years. All patients 
were right-handed. They had been in school for at least 5 
years and three of them had a high level of education. Three 
patients had a history of arterial hypertension, two patients 
underwent operation for prostatic adenoma, and four had 
a history of familial PD. The mean duration of the disease 
was 5.4 years (range 11 months–12 years). The staging of PD 
for these patients was based on the Hoehn and Yahr scale. 
Two of our patients were classified as stage I, six of them as 
stage II, and ten as stage III (Hoehn and Yahr, 1967). Table 
1 summarizes the demographic and clinical profile of the 
included patients with PD.
fMRI assessment results
Different brain structures (in particular the occipito-tempo-
ral cortices, insula, orbitofrontal cortex, basal ganglia, and 
parietal cortex) involved in the organization of emotions 
were activated during the functional control. In addition, 
the activation level depended on the emotion type of stimuli. 
Thus, positive emotion was shown to activate larger volumes 
of the anatomical entities involved in the emotional process-
ing in all patients. However, the importance of activation 
decreased significantly in the negative emotion compared 
with the positive emotion (Figure 3). 
Figure 2 Block design paradigm showing the arrangement of the emotional tasks (positive, negative, and neutral).
Each emotional task was repeated three times with unique images, e.g. each picture was displayed once. 
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Figure 4 Whole brain blood oxygenation level-dependent activation 
elicited by positive, negative, and neutral emotions in the group of 
patients studied. 
The bars represent activation scores, and the error bars represent the 
standard error.  
The global activation induced by the positive, negative, 
and neutral emotions was quantitatively evaluated (Figure 
4). In PD patients, positive emotion had the largest activa-
tion area and negative emotion had the smallest activation 
area (Figure 4). 
Statistical analysis
Global brain activation level in each motion category (pos-
itive, negative, and neutral) was statistically analyzed using 
analysis of variance. Positive and negative emotions produced 
significantly different effects on global brain activation level. 
Quantitative statistical analysis results demonstrated signif-
icant difference in the brain activation level associated with 
positive versus negative emotions (P < 0.05). However, there 
was no significant difference in the brain activation level be-
tween negative and neutral emotions (P > 0.05). 
Discussion
PD is a neurodegenerative disorder characterized by deple-
tion of dopaminergic neurons in specific brain anatomic 
entity called substantia nigra. This degenerative process 
of the nigrostriatal dopaminergic pathway instigates the 
impairment of the basal ganglia-thalamo-cortical circuit 
functions, including the motor and prefrontal cortex func-
tions (Alexander et al., 1990). Besides motor symptoms, PD 
patients exhibit cognitive dysfunction (Jankovic, 2008; Hsu 
Figure 3 Blood oxygenation level-dependent activations in three Parkinson’s disease patients showing that positive emotion activates larger 
volumes of the brain networks involved in emotional processing, compared to neutral and negative emotions. 
Green, orange and red faces to the left indicate activations in response to positive emotions (brain slices inside the green frame), neutral stimuli 
(orange frame) and negative emotions (red frame) respectively. A color scale is inserted next to each set of images to indicate the intensity of activa-
tions (black, no activation; yellow, highest activation). 
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et al., 2012) and a deficit in emotional processing (Assogna 
et al., 2008; Gray and Tickle-Degnen, 2010).
The basal ganglia are crucial structures for emotion rec-
ognition. Stroke (Fromm et al., 1985; Pogarell and Oertel, 
1999) or other neurodegenerative diseases, such as Hun-
tington’s disease (Robotham et al., 2011) damage the basal 
ganglia, leading to marked deficits in emotion recognition. 
Mauss and Robinson (2009) reported that the state of emo-
tion in PD involves a series of brain circuits rather than spe-
cific isolated brain regions. Moreover, the cortical and sub-
cortical brain structures are involved together in emotional 
processing through cortical-thalamic-striatal cognitive loops 
(Owen et al., 1998). The limbic system represents the most 
important basal ganglia-thalamo-cortical circuits, which 
has a crucial role in emotional and motivational processes 
(Butters et al., 1973; Afifi, 2003). BOLD-fMRI studies have 
revealed an increased activation of orbitofrontal cortex and 
anterior cingulated cortex when volunteers are experiencing 
to recognize emotions using facial expressions (Dolan et al., 
1996; Blair et al., 1999). Besides, impairment of emotional 
identification has been demonstrated in patients with or-
bitofrontal cortex and/or anterior cingulate cortex lesions 
using facial expressions (Hornak et al., 2003).
Several assessment methods such as BOLD-fMRI, positron 
emission tomography, PET scan, and electroencephalogra-
phy were used to analyze interconnected neuronal activities 
in various brain regions to detect the activation yielded by 
emotional processing in the brain. Baumgartner et al. (2006) 
reported that electroencephalography activity in the left 
hemisphere was increased under happy conditions compared 
to negative emotional conditions. Hinrichs and Machleidt 
(1992) demonstrated a changed degree of coherence in the 
alpha frequency band on electroencephalography, principally 
with a larger coherence in happiness compared to sadness. 
A recent meta-analysis regarding fMRI of emotional pro-
cessing has suggested that basic emotions are implemented by 
different neural circuits, and each type of emotion activates 
preferentially a specific brain region (Fusar-Poli et al., 2009). 
Happy and fearful faces activate bilateral amygdala, sad faces 
activate the right amygdala only, and disgusting faces seem to 
activate essentially the anterior insula (Phan et al., 2002).
Numerous studies have found emotion recognition deficits 
in patients with PD (Jacobs et al., 1995; Benke et al., 1998; 
Breitenstein et al., 1998; St. Clair et al., 1998). Breitenstein 
et al. (1998) reported that compared to healthy controls, 
patients with PD performed poorer in commenting the emo-
tional content of speech or sketches (Scott et al., 1984) and in 
recognizing emotional displays, in particular in prosodic rec-
ognition tasks involving anger and fear. PD patients showed 
reduced recognition of sadness, anger, and disgust facial ex-
pressions (St.Clair et al., 1998; Baggio et al., 2012). 
With regard to recognition of emotional facial expression, a 
recent meta-analysis evaluating behavioral studies found that 
individuals with PD exhibited more severe impairment than 
healthy individuals in the recognition of negative emotions 
(anger, disgust, fear, and sadness) and individuals with PD 
exhibited more severe impairment in the recognition of neg-
ative emotions than in the recognition of positive emotions 
(happiness, surprise) (Gray and Tickle-Degnen, 2010). This 
problem is likely related to disturbances in the limbic loop, 
and in particular in the connections of the basal ganglia to the 
orbitofrontal cortex and anterior cingulated cortex.  
Interestingly, a relationship was demonstrated between 
the expression of facial emotions by both PD patients and 
healthy volunteers and the ability to recognize facial emo-
tions expressed by others (Ariatti et al., 2008). The capability 
of recognizing the emotions expressed by others is based on 
the processes that internally stimulate the identical emotional 
state in each individual (Scott et al., 1984; Heberlein and At-
kinson., 2009; Baggio et al., 2012). This is called the simulation 
or goal directed model of emotion recognition which depends 
on the mirror neurons located in F5 brain area within the pars 
opercularis of the inferior frontal gyrus (Rizzolatti and Arbib, 
1998).
In our study, we demonstrated that brain activation is weak-
er in negative emotion. Wieser et al. (2006) found that PD pa-
tients rated negative pictures as less arousing than did healthy 
controls, but they had no such problem in accurately rating 
positive and neutral pictures. Alonso-Recio et al. (2014) found 
also that patients with higher disease severity performed worse 
than healthy controls in the recognition of emotional facial ex-
pressions, however, such result was not found in patients with 
lower disease severity. 
PD patients’ deficits in the recognition of negative emo-
tions may be related to faulty communication between the 
amygdala and prefrontal cortex due to low levels of dopamine 
(Lin et al., 2016). As supported by the present study, in PD pa-
tients, there is a reduction in the brain complexity during emo-
tional processing initiated by a decrease of neural connectivity 
and the existence of functional disconnections between cortical 
areas (Adolphs et al., 1996; Lawrence et al., 2006; Kober et al., 
2008; Cronin-Golomb, 2010; Lin et al., 2016).
In addition, dopamine levels have been shown to be correlat-
ed with patients’ performance when recognizing facial emo-
tions (Sprengelmeyer et al., 2003; Lawrence et al., 2007). Motor 
performances and cognitive functions worsen over time in PD 
patients because of dopaminergic neurodegeneration.
Our study showed that positive emotion activates large vol-
umes of the anatomical entities involved in the emotional 
processing in PD patients. However, the negative emotions 
activate the least area of brain regions in the same PD pa-
tients. As the disease progresses, the recognition of negative 
emotions is impaired and then followed impairment to the 
recognition of positive emotions (Lawrence et al., 2007). 
These facts are supported by physiological data. It is well 
known that prefrontal dopamine influences cognitive func-
tions (Arnsten et al., 2005; Cools and D’Esposito, 2011). 
Interestingly, dopamine uptake has been reported to be in-
creased in prefrontal regions (Rakshi et al., 1999; Kaasimnen 
et al., 2000; Cools et al., 2002) in early PD. However, later 
in the disease, PET scanning revealed marked decrease in 
prefrontal dopamine and in D2-type dopamine receptors 
(Kaasinen et al., 2000; Rakshi et al., 2001; Yip et al., 2003). 
Based on this, we could speculate that preservation of rec-
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ognition of positive emotion in our PD patients is related to 
the presence of dopamine reserve in the prefrontal cortex. 
However, the heterogeneity and the small sample of our 
population might be a limitation that should be considered. 
Future clinical and in vivo molecular imaging studies (e.g., 
PET/SPECT) of patients with early PD may resolve this 
question. 
Finally, Yip et al. (2003) found that compared to unilateral 
PD patients, bilateral PD patients showed greater deficits in the 
emotion recognition task regardless of the stimulus modality.
Conclusion
Emotion is an essential tool for social communication be-
tween individuals. Because of dopaminergic degeneration, 
emotion is affected in PD similar to motor function. Thus, 
clinicians should be aware of this fact to identify the emo-
tional impairment in PD patients and to direct specific 
treatment for the patients, such as computerized cognitive 
rehabilitation (Yuvaraj et al., 2016).  
Our study demonstrated a specific impairment of negative 
emotional processing in PD patients. This result could be ex-
plained by our demographic data since all patients were rel-
atively in the early stage of the disease. Nevertheless, we be-
lieve that prospective studies using clinical/fMRI emotional 
tests and involving larger number of PD patients would be 
the best way to confirm this hypothesis.
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